Dr Reddy's Laboratories (Dr Reddy's Laboratories) 10-Year ROIIC % : 27.43% (As of Mar. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Dr Reddy's Laboratories's 10-Year ROIIC % for the quarter that ended in Mar. 2023 was 27.43%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Dr Reddy's Laboratories's 10-Year ROIIC % or its related term are showing as below:

RDY's 10-Year ROIIC % is ranked better than
84.18% of 986 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs RDY: 27.43

Dr Reddy's Laboratories 10-Year ROIIC % Historical Data

The historical data trend for Dr Reddy's Laboratories's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories 10-Year ROIIC % Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

10-Year ROIIC %

Get a 7-Day Free Trial

2.27

26.67

10.59

10.84

27.43

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
10-Year ROIIC %	Get a 7-Day Free Trial															-	27.43	-	-	-

Competitive Comparison of Dr Reddy's Laboratories's 10-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's 10-Year ROIIC % falls into.

Dr Reddy's Laboratories 10-Year ROIIC % Calculation

Dr Reddy's Laboratories's 10-Year ROIIC % for the quarter that ended in Mar. 2023 is calculated as:

10-Year ROIIC %	=	10-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	10-Year Incremental Invested Capital^**
	=	( 535.9378508 (Mar. 2023) - 298.1813483 (Mar. 2013) )	/	( 2401.707 (Mar. 2023) - 1763.853 (Mar. 2013) )
	=	237.7565025	/	637.854
	=	37.27%^***

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Dr Reddy's Laboratories (NYSE:RDY) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Dr Reddy's Laboratories 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » 10-Year ROIIC %

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.